Company Profile

APOLLO HOSPITALS ENTERPRISE LTD.

NSE : APOLLOHOSPBSE : 508869ISIN CODE : INE437A01024Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE3133.3018.95 (+0.61 % )
PREV CLOSE (Rs.) 3114.35
OPEN PRICE (Rs.) 3160.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 48045
TODAY'S LOW / HIGH (Rs.)3107.45 3163.55
52 WK LOW / HIGH (Rs.)1230.25 3283.9
NSE3132.15 17.55 (+0.56 % )
PREV CLOSE(Rs.) 3114.60
OPEN PRICE (Rs.) 3147.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 3132.15 (51 )
VOLUME 934037
TODAY'S LOW / HIGH(Rs.) 3105.90 3164.15
52 WK LOW / HIGH (Rs.)1229.8 3284

Company News

Date Heading Details
20-Mar-2021 Apollo Hospitals Enterprises informs about loss of share certificate <P align=justify>Apollo Hospitals Enterprises has informed that the Company has received intimation from shareholder on March 19, 2021 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are enclosed.<P align=justify>The above information is a part of company's filings submitted to BSE.<BR>
18-Feb-2021 Apollo Hospitals Group, Anatomiz3D Medtech to establish 3D-printing labs in various Apollo Hospitals in India <p align="justify">Apollo Hospitals Group and Anatomiz3D Medtech will establish 3D-printing labs in various Apollo Hospitals in India, starting from Apollo Health City in Hyderabad. The hospital's 3D-printing labs would provide medical 3D printing services for better healthcare, through the creation of anatomical models for pre-surgical planning and education, patient-specific cutting and drilling guides, and customised implants and implant moulds. As healthcare evolves, 3D-printing will play an important part of this future transformation. &nbsp;</p><p align="justify">Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.<br></p>
15-Feb-2021 Apollo Hospitals Enterprise reports 42% rise in Q3 consolidated net profit <P align=justify>Apollo Hospitals Enterprise has reported results for third quarter ended December 31, 2020.<P align=justify>The company has reported a rise of 12.11% in its net profit at Rs 106.22 crore for the quarter under review as compared to net profit at Rs 94.75 crore for the same quarter in the previous year. However, total income of the company decreased by 6.50% at Rs 2367.94 crore for Q3FY21 as compared Rs 2532.51 crore for the corresponding quarter previous year.<P align=justify>On the consolidated basis, the company has reported 41.56% rise in its net profit attributable to owners at Rs 130.43 crore for the quarter under review as compared to net profit at Rs 92.14 crore for the same quarter in the previous year. However, total income of the company decreased by 5.34% at Rs 2765.34 crore for Q3FY21 as compared Rs 2921.40 crore for the corresponding quarter previous year.
15-Feb-2021 Apollo Hospitals trades jubilantly on reporting 42% rise in Q3 consolidated net profit <P align=justify>Apollo Hospitals Enterprise is currently trading at Rs. 3006.30, up by 258.95 points or 9.43% from its previous closing of Rs. 2747.35 on the BSE.<P align=justify>The scrip opened at Rs. 2788.00 and has touched a high and low of Rs. 3021.65 and Rs. 2761.05 respectively. So far 92894 shares were traded on the counter.<P align=justify>The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3,032.95 on 15-Feb-2021 and a 52 week low of Rs. 1047.45 on 31-Mar-2020.<P align=justify>Last one week high and low of the scrip stood at Rs. 3032.95 and Rs. 2723.60 respectively. The current market cap of the company is Rs. 43297.87 crore.<P align=justify>The promoters holding in the company stood at 30.82%, while Institutions and Non-Institutions held 62.55% and 6.40% respectively.<P align=justify>Apollo Hospitals Enterprise has reported a rise of 12.11% in its net profit at Rs 106.22 crore for the quarter ended December 31, 2020 as compared to net profit at Rs 94.75 crore for the same quarter in the previous year. However, total income of the company decreased by 6.50% at Rs 2367.94 crore for Q3FY21 as compared Rs 2532.51 crore for the corresponding quarter previous year.<P align=justify>On the consolidated basis, the company has reported 41.56% rise in its net profit attributable to owners at Rs 130.43 crore for the quarter ended December 31, 2020 as compared to net profit at Rs 92.14 crore for the same quarter in the previous year. However, total income of the company decreased by 5.34% at Rs 2765.34 crore for Q3FY21 as compared Rs 2921.40 crore for the corresponding quarter previous year.
01-Feb-2021 Healthcare stocks trade in green on introducing Aatmanirbharbharat Health Yojana with outlay of Rs 64,180 crore <P align=justify>Healthcare stocks gained as FM introduced Aatmanirbharbharat Health Yojana with outlay of Rs 64,180 crore<P align=justify>Apollo Hospitals Enterprise is currently trading at Rs. 2585.05, up by 23.00 points or 0.90% from its previous closing of Rs. 2562.05 on the BSE. The scrip opened at Rs. 2570.00 and has touched a high and low of Rs. 2619.50 and Rs. 2530.75 respectively. So far 9474 shares were traded on the counter.<P align=justify>Max Healthcare Institute is currently trading at Rs. 170.00, up by 7.95 points or 4.91% from its previous closing of Rs. 162.05 on the BSE.The scrip opened at Rs. 164.80 and has touched a high and low of Rs. 171.00 and Rs. 163.50 respectively. So far 22156 shares were traded on the counter.<P align=justify>Fortis Healthcare is currently trading at Rs. 163.50, up by 1.90 points or 1.18% from its previous closing of Rs. 161.60 on the BSE. The scrip opened at Rs. 161.60 and has touched a high and low of Rs. 163.95 and Rs. 161.20 respectively. So far 40715 shares were traded on the counter.
28-Jan-2021 Announcement under Regulation 30 (LODR)-Scheme of Arrangement of Directors of the company had approved the Scheme of Amalgamation of Apollo Home Healthcare (India) Limited and Western Hospitals Corporation Private Limited, wholly owned subsidiaries of the Company (hereinafter referred to as 'Transferor Companies') into Apollo Hospitals Enterprise Limited (Transferee Company) under Sections 230 - 232 of the Companies Act, 2013 We would like to inform you that the Board of Directors on 27th January 2021 approved to go ahead with a revised Scheme of amalgamation of the above said Transferor Companies into the Transferee Company under the fast track merger scheme as contemplated under Section 233 of the Companies Act, 2013. The amalgamation is subject to requisite statutory and regulatory approvals and sanction by the respective shareholders of each of the Companies involved in the scheme.
28-Jan-2021 Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended December 31, 2020 APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Further to our letter dated 29th December 2020 and pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will be meeting on Friday, February 12, 2021, inter alia, consider the approval of the unaudited financial results for the quarter and nine months ended 31st December 2020 and other related matters. Further in accordance with the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window would continue to remain closed for Promoters, Directors, other connected persons and designated employees of the Company from January 1, 2021 till 48 hours after the announcement of financial results i.e., upto February 14, 2021.
23-Jan-2021 QIP A meeting of the Fund Raising Committee of the Company shall be held on January 22,2021 to inter alia, consider and determine the issue price of Equity Shares to be issued pursuant to the QlP, including any discount on the floor price calculated in accordance with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the "SEBI ICDR Regulations") and as permitted by the SEBI ICDR Regulations and approved by the shareholders pursuant to a resolution dated January 9, 2021.
18-Jan-2021 Preferential Issue of Shares Preferential Issue of shares Pursuant to the approval accorded by the board of directors of the Company (the "Board"), at its meeting held on November 11, 2020 and special resolution passed by the members of the Company by way of postal ballot on January 9,2021, the Fund Raising Committee has, at its meeting held today, on, January 18, 2021, inter-alia, considered and approved the following: (a) approval and adoption of the preliminary placement document dated January 18, 2021 and the application form dated January 18, 2021 in connection with the Issue; and (b) authorisation of the opening of the Issue today, i.e., January 18, 2021. 2. We further wish to inform you that the Fund Raising Committee has fixed the 'Relevant Date' for the purpose of the Issue, in terms of Regulation 171 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ("SEBI ICDR Regulations"), as January 18, 2021, and accordingly the floor price in respect of the aforesaid Issue based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations is 2,508.58 per Equity Share. Pursuant to Regulation 176(1) of the SEBI ICDR Regulations, the Company may offer a discount of not more than 5% on the floor price so calculated for the Issue.
18-Jan-2021 QIP Announcement A meeting of the Fund Raising Committee of the Company shall be held on January 22,2021 to inter alia, consider and determine the issue price of Equity Shares to be issued pursuant to the QlP, including any discount on the floor price calculated in accordance with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the "SEBI ICDR Regulations") and as permitted by the SEBI ICDR Regulations and approved by the shareholders pursuant to a resolution dated January 9, 2021.